Published in Cochrane Database Syst Rev on January 21, 2009
Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting | NCT00235911
Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J (2012) 1.96
Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis. BMJ (2014) 1.67
Management of severe asthma in children. Lancet (2010) 1.60
Comparative effectiveness of asthma interventions within a practice based research network. BMC Health Serv Res (2011) 0.92
Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma. Cochrane Database Syst Rev (2010) 0.92
Concordance of effects of medical interventions on hospital admission and readmission rates with effects on mortality. CMAJ (2013) 0.80
Effects of bambuterol and terbutaline on isolated rat's tracheal smooth muscle. Eur Arch Otorhinolaryngol (2009) 0.75
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med (2006) 7.83
Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med (2004) 4.37
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet (2006) 3.93
Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet (2004) 3.89
Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest (2006) 2.75
Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial. Lancet (2001) 2.68
Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2008) 2.38
Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax (2004) 2.13
Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med (1999) 1.96
Effect of long-acting beta2 agonists on exacerbation rates of asthma in children. Pediatr Pulmonol (2003) 1.92
Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J (2005) 1.70
Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract (2007) 1.64
Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin (2004) 1.57
Regular treatment with formoterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2008) 1.57
Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Cochrane Database Syst Rev (2005) 1.56
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med (2007) 1.35
Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest (2006) 1.33
Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Cochrane Database Syst Rev (2005) 1.19
Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid. Cochrane Database Syst Rev (2007) 1.17
Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers. Pulm Pharmacol Ther (2001) 1.10
Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study. Curr Med Res Opin (2006) 1.06
Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma. Eur Respir J (2008) 1.03
Safety of formoterol by Turbuhaler as reliever medication compared with terbutaline in moderate asthma. Eur Respir J (2002) 1.02
Fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database Syst Rev (2008) 1.01
Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help? Br J Gen Pract (2008) 0.93
A cost-effectiveness study comparing the as-needed use of formoterol (Oxis) and terbutaline (Bricanyl) in patients with moderate to severe asthma. Respir Med (2001) 0.91
Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy. Allergy (2007) 0.90
Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma. Curr Med Res Opin (2007) 0.85
Acute asthma intervention: insights from the STAY study. J Allergy Clin Immunol (2007) 0.84
Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma. Pharmacoeconomics (2006) 0.84
Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA study. Eur Respir J (2006) 0.83
Randomised trial comparing as-needed versus regular treatment with formoterol in patients with persistent asthma. Respir Med (2006) 0.83
Maintenance and symptom relief with budesonide plus formoterol reduced severe asthma exacerbations. Evid Based Nurs (2005) 0.81
A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma. Respir Med (2008) 0.80
Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study. Respir Res (2006) 0.79
Influenza vaccination for healthcare workers who work with the elderly. Cochrane Database Syst Rev (2010) 2.91
Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2008) 2.38
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2012) 1.95
Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev (2011) 1.80
Influenza vaccination for healthcare workers who work with the elderly: systematic review. Vaccine (2010) 1.71
Pressure modification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. Cochrane Database Syst Rev (2009) 1.58
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2010) 1.58
Regular treatment with formoterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2008) 1.57
Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev (2010) 1.52
Interventions for educating children who are at risk of asthma-related emergency department attendance. Cochrane Database Syst Rev (2009) 1.38
Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. Cochrane Database Syst Rev (2013) 1.34
Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children. Cochrane Database Syst Rev (2009) 1.33
Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. Cochrane Database Syst Rev (2014) 1.24
Fluticasone at different doses for chronic asthma in adults and children. Cochrane Database Syst Rev (2008) 1.20
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database Syst Rev (2010) 1.16
Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines for adults with obstructive sleep apnoea. Cochrane Database Syst Rev (2009) 1.16
Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children. Cochrane Database Syst Rev (2009) 1.14
Fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database Syst Rev (2008) 1.01
Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. Cochrane Database Syst Rev (2011) 1.00
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2009) 0.93
Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev (2009) 0.92
Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2009) 0.91
Herbal interventions for chronic asthma in adults and children: a systematic review and meta-analysis. Prim Care Respir J (2010) 0.88
Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. Cochrane Database Syst Rev (2016) 0.87
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2009) 0.79
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2012) 0.75
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Sao Paulo Med J (2010) 0.75